Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof the correspond to a novel human secreted stem cell growth factor-like polypeptide. These polypeptides comprise nucleic acid sequences isolated from cDNA libraries prepared from human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invertion include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Abstract: A fluidizing apparatus includes a supply duct (1) for supplying liquid under pressure to a lower portion of a vessel (11) containing a fluidizable material. The supply duct (1) extends into the vessel. The outlet end of the apparatus includes one or more jets (212) for directing the flow of liquid into the vessel (11) substantially transversely to the major axis of the supply duct (1). An outlet duct (12) for removing the fluidized material from the vessel (11) is also included.

Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human and mouse secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from mouse bone marrow and human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, placental, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human stem cell growth factor-like protein.

Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Abstract: An edit-to-it function of an editing system allows an editor to combine linear editing with non-linear editing. A linear source, such as a magnetic tape, may be identified as an edit source, as well as already predigitized material. When the linear source is selected as an edit source, an edit-to-it file is created that indicates the status of the source--which portions are already digitized and which are not. The editor identifies an in-point on the edit and an in-point on the source. The source prerolls, as applicable, to the in-point and lays the shot into the edit while simultaneously recording the shot including a handle prior to the in-point into a digital storage device. When the editor identifies the end of the shot, either by a predetermined out-point or on-the-fly, the source stops and the recording terminates.